Detail akcie Zimmer Hldgs online

Business Summary: Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
Financial Summary: BRIEF: For the nine months ended 30 September 2024, Zimmer Biomet Holdings Inc revenues increased 4% to $5.66B. Net income applicable to common stockholders increased 10% to $664.3M. Revenues reflect Americas segment increase of 3% to $3.52B, EMEA segment increase of 7% to $1.25B, Asia Pacific segment increase of less than 1% to $880.3M, International segment increase of 5% to $2.4B, United States segment increase of 3% to $3.26B.